Montag & Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.29K | Buy |
+90
| New | +$6.29K | ﹤0.01% | 780 |
|
|
2025
Q1 | – | Sell |
-10
| Closed | -$656 | – | 1000 |
|
|
2024
Q4 | $656 | Hold |
10
| – | – | ﹤0.01% | 976 |
|
|
2024
Q3 | $780 | Buy |
+10
| New | +$780 | ﹤0.01% | 998 |
|
|
2018
Q2 | – | Sell |
-9,400
| Closed | -$329K | – | 279 |
|
|
2018
Q1 | $329K | Hold |
9,400
| – | – | 0.03% | 236 |
|
|
2017
Q4 | $326K | Hold |
9,400
| – | – | 0.03% | 238 |
|
|
2017
Q3 | $318K | Hold |
9,400
| – | – | 0.03% | 213 |
|
|
2017
Q2 | $320K | Hold |
9,400
| – | – | 0.04% | 208 |
|
|
2017
Q1 | $293K | Hold |
9,400
| – | – | 0.03% | 211 |
|
|
2016
Q4 | $257K | Hold |
9,400
| – | – | 0.03% | 218 |
|
|
2016
Q3 | $309K | Hold |
9,400
| – | – | 0.04% | 210 |
|
|
2016
Q2 | $284K | Hold |
9,400
| – | – | 0.04% | 211 |
|
|
2016
Q1 | $265K | Hold |
9,400
| – | – | 0.04% | 214 |
|
|
2015
Q4 | $319K | Hold |
9,400
| – | – | 0.05% | 192 |
|
|
2015
Q3 | $299K | Hold |
9,400
| – | – | 0.05% | 196 |
|
|
2015
Q2 | $299K | Hold |
9,400
| – | – | 0.04% | 209 |
|
|
2015
Q1 | $322K | Hold |
9,400
| – | – | 0.05% | 210 |
|
|
2014
Q4 | $331K | Buy |
+9,400
| New | +$331K | 0.05% | 203 |
|